PPJ Healthcare Enterprises, Inc.
PPJE · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| FCF Yield | 24,623.67% | -26,778.36% | -0.36% | 454.73% |
| EV / EBITDA | 118,281.68 | -81.21 | -679.30 | 86.87 |
| Quality | ||||
| ROIC | 0.00% | -0.21% | -0.04% | 0.23% |
| Gross Margin | 25.86% | 3.05% | 20.32% | 24.48% |
| Cash Conversion Ratio | 99,668.82 | 76.84 | 1.00 | 70.66 |
| Growth | ||||
| Revenue 3-Year CAGR | -4.82% | -5.57% | -10.02% | -4.62% |
| Free Cash Flow Growth | 188.96% | -38,292.68% | -100.26% | 3.88% |
| Safety | ||||
| Net Debt / EBITDA | 117,876.91 | -80.92 | -401.98 | 71.34 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 64.85 | 38.53 | 24.81 | 19.46 |
| Cash Conversion Cycle | 1,210.52 | 1,272.57 | 1,002.75 | 1,114.01 |